Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up - Should You Buy?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares gapped up from $71.88 to $76.37 before trading on Thursday, last trading at $76.28 with minimal volume.
  • Analysts maintain a consensus rating of "Hold" on Eurofins Scient, with one analyst recommending a Strong Buy and five others suggesting Hold.
  • The company's fundamentals show a current ratio of 1.26, quick ratio of 1.19, and a debt-to-equity ratio of 0.77, indicating a stable financial position.
  • Interested in Eurofins Scient? Here are five stocks we like better.

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $71.88, but opened at $76.37. Eurofins Scient shares last traded at $76.28, with a volume of 5 shares.

Wall Street Analysts Forecast Growth

Separately, Citigroup restated a "neutral" rating on shares of Eurofins Scient in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold".

View Our Latest Stock Analysis on Eurofins Scient

Eurofins Scient Trading Up 5.5%

The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77. The stock's fifty day simple moving average is $76.33 and its 200-day simple moving average is $68.01.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.